XML 355 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Derivative instruments
12 Months Ended
Dec. 31, 2019
Derivative [Line Items]  
Disclosure Of Derivative Financial Instruments Explanatory

Note 11 Derivative instruments

Derivatives: overview

A derivative is a financial instrument for which the value is derived from one or more variables (underlyings). Underlyings may be indices, foreign currency exchange or interest rates, or the value of shares, commodities, bonds or other financial instruments. A derivative commonly requires little or no initial net investment by either counterparty to the trade.

The majority of derivative contracts are negotiated with respect to notional amounts, tenor, price and settlement mechanisms, as is customary with other financial instruments.

Over-the-counter (OTC) derivative contracts are usually traded under a standardized International Swaps and Derivatives Association (ISDA) master agreement between UBS and its counterparties. Terms are negotiated directly with counterparties and the contracts have industry standard settlement mechanisms prescribed by ISDA. Beginning in 2016, regulators in various jurisdictions began a phased introduction of rules requiring the payment and collection of initial and variation margin on certain OTC derivative contracts, which may have a bearing on their price and other relevant terms. Under the final rules of the Basel Committee on Banking Supervision (BCBS) and the Board of the International Organization of Securities Commissions (IOSCO) promulgated in July 2019, the final phase-in of margin requirements for non-centrally cleared derivatives will be completed on 1 September 2021.

The industry continues to promote the use of central counterparties (CCPs) to clear OTC trades. The trend toward CCP clearing and settlement will generally facilitate the reduction of systemic credit exposures.

Other derivative contracts are standardized in terms of their amounts and settlement dates, and are bought and sold on regulated exchanges. These are commonly referred to as exchange-traded derivatives (ETD) contracts. Exchanges offer the benefits of pricing transparency, standardized daily settlement of changes in value and consequently reduced credit risk.

For presentation purposes, the Group’s derivative contracts are subject to IFRS netting provisions. Derivative instruments are measured at fair value and generally classified on the balance sheet as Derivative financial instruments within Assets when having positive replacement values and Derivative financial instruments within Liabilities when having negative replacement values. However, ETD that are economically settled on a daily basis and OTC derivatives that are either legally settled or in substance net settled on a daily basis are classified as Cash collateral receivables on derivative instruments or Cash collateral payables on derivative instruments. Changes in the replacement values of derivatives are recorded in Other net income from financial instruments measured at fair value through profit or loss, except for interest on derivatives designated as hedging instruments in effective hedge accounting relationships and forward points on certain short- and long-duration foreign exchange contracts, which are recorded in Net interest income.

Refer to Note 1a items 3j and 3k for more information

Refer to Note 25 for more information about derivative financial assets and liabilities after consideration of netting potential allowed under enforceable netting arrangements

The Group uses various derivative instruments for both trading and hedging purposes. Derivative product types as well as valuation principles and techniques applied by the Group are described in Note 24. Positive replacement values represent the estimated amount the Group would receive if the derivative contract were sold on the balance sheet date. Negative replacement values indicate the estimated amount the Group would pay to transfer its obligations in respect of the underlying contract were it required or entitled to do so on the balance sheet date.

Derivatives embedded in other financial instruments are not included in the “Derivative instruments” table within this Note. Bifurcated embedded derivatives are presented on the same balance sheet line as the host contract. In cases where UBS applies the fair value option to hybrid instruments, bifurcation of an embedded derivative component is not required and as such this component is also not included in the “Derivative instruments” table.

Refer to Notes 19 and 24 for more information

Note 11 Derivative instruments (continued)

Derivative instruments¹,²

31.12.1931.12.18
USD billionDerivativefinancialassetsNotional valuesrelated to derivativefinancial assets3DerivativefinancialliabilitiesNotional valuesrelated to derivativefinancial liabilities3Other notional values3, 4DerivativefinancialassetsNotional valuesrelated to derivativefinancial assets3DerivativefinancialliabilitiesNotional valuesrelated to derivativefinancial liabilities3Other notional values3, 4
Interest rate contracts
Over-the-counter (OTC) contracts
Forward contracts 0.0 2.8 0.3 5.1 3,136.8 0.0 1.4 0.1 3.1 2,873.9
Swaps 34.3 454.7 26.2 402.9 8,086.0 29.5 459.8 23.5 441.8 7,189.1
Options 8.1 464.8 10.0 486.1 7.6 562.2 9.0 550.0
Exchange-traded contracts
Futures 546.9 516.1
Options 0.0 84.4 0.0 66.6 229.5 0.0 27.7 0.0 26.3 199.7
Agency transactions5 0.1 0.1 0.0 0.1
Total 42.6 1,006.6 36.6 960.7 11,999.2 37.1 1,051.1 32.7 1,021.3 10,778.8
Credit derivative contracts
Over-the-counter (OTC) contracts
Credit default swaps 1.7 65.0 2.2 66.0 1.7 68.8 2.1 73.2
Total return swaps 0.3 2.0 0.8 3.3 0.2 3.0 0.6 3.7
Options and warrants 0.0 3.3 0.0 0.6 0.0 2.7 0.0 1.4
Total 2.0 70.2 3.0 69.9 1.9 74.5 2.7 78.3
Foreign exchange contracts
Over-the-counter (OTC) contracts
Forward contracts 22.4 935.3 23.4 966.6 20.3 708.7 20.9 731.2
Interest and currency swaps 22.8 1,573.2 23.8 1,418.5 24.8 1,299.7 24.6 1,203.5
Options 7.3 660.9 6.8 604.9 8.3 613.8 7.8 577.4
Exchange-traded contracts
Futures 1.2 0.4
Options 0.0 4.0 0.0 3.8 0.0 3.6 0.0 5.3
Agency transactions5 0.0 0.0 0.0 0.1
Total 52.5 3,173.4 54.0 2,993.8 1.2 53.5 2,625.7 53.4 2,517.3 0.4
Equity / index contracts
Over-the-counter (OTC) contracts
Forward contracts 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Swaps 4.0 81.3 5.5 96.3 4.7 78.5 5.6 86.3
Options 5.0 88.6 6.8 144.1 5.5 97.6 7.2 139.6
Exchange-traded contracts
Futures 84.9 71.7
Options 7.2 250.4 7.8 294.1 37.2 10.1 232.8 9.0 262.8 34.1
Agency transactions5 6.6 5.4 11.2 13.3
Total 22.8 420.3 25.5 534.5 122.1 31.4 408.9 35.0 488.8 105.9
31.12.1931.12.18
USD billionDerivativefinancialassetsNotional valuesrelated to derivativefinancial assets3DerivativefinancialliabilitiesNotional valuesrelated to derivativefinancial liabilities3Other notional values3, 4DerivativefinancialassetsNotional valuesrelated to derivativefinancial assets3DerivativefinancialliabilitiesNotional valuesrelated to derivativefinancial liabilities3Other notional values3, 4
Commodity contracts
Over-the-counter (OTC) contracts
Forward contracts 0.1 4.2 0.2 5.7 0.1 3.2 0.1 3.4
Swaps 0.4 13.8 0.6 15.1 0.7 15.2 0.4 9.9
Options 1.0 27.4 0.4 23.6 0.4 18.6 0.3 16.1
Exchange-traded contracts
Futures 12.0 8.5
Forward contracts 0.0 5.9 0.0 4.9 0.0 6.6 0.0 5.4
Options 0.1 4.8 0.1 10.7 0.6 0.1 2.9 0.0 3.7 0.1
Agency transactions5 0.3 0.5 0.4 0.7
Total 1.8 56.1 1.7 60.0 12.6 1.8 46.4 1.5 38.5 8.6
Unsettled purchases of non-derivative financial instruments6 0.1 16.6 0.1 6.9 0.2 17.0 0.1 6.0
Unsettled sales of non-derivative financial instruments6 0.1 15.4 0.1 9.7 0.4 15.1 0.2 13.2
Total derivative instruments, based on IFRS netting7 121.8 4,758.6 120.9 4,635.4 12,135.1 126.2 4,238.6 125.7 4,163.4 10,893.6
1 Derivative financial liabilities as of 31 December 2019 include USD 17 million related to derivative loan commitments (31 December 2018: USD 17 million). No notional amounts related to these commitments are included in this table, but they are disclosed in Note 34 under Loan commitments. 2 Includes certain forward starting repurchase and reverse repurchase agreements that are classified as measured at fair value through profit or loss and are recognized within derivative instruments. The fair value of these derivative instruments was not material as of 31 December 2019 or 31 December 2018. No notional amounts related to these instruments are included in this table, but they are disclosed in Note 34 under Forward starting transactions. 3 In cases where derivative financial instruments are presented on a net basis on the balance sheet, the respective notional values of the netted derivative financial instruments are still presented on a gross basis. 4 Other notional values relate to derivatives that are cleared through either a central counterparty or an exchange. The fair value of these derivatives is presented on the balance sheet net of the corresponding cash margin under Cash collateral receivables on derivative instruments and Cash collateral payables on derivative instruments and was not material for all periods presented. 5 Notional values of exchange-traded agency transactions and OTC-cleared transactions entered into on behalf of clients are not disclosed as they have a significantly different risk profile. 6 Changes in the fair value of purchased and sold non-derivative financial instruments between trade date and settlement date are recognized as derivative financial instruments. 7 Financial assets and liabilities are presented net on the balance sheet if UBS has the unconditional and legally enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of the entity and all of the counterparties, and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously. Refer to Note 25 for more information on netting arrangements.

The notional amount of a derivative is generally the quantity of the underlying instrument on which the derivative contract is based and is the reference against which changes in the value of the derivative are measured. Notional values in themselves are generally not a direct indication of the values that are exchanged between parties, and are therefore not a direct measure of risk or financial exposure but are viewed as an indication of the scale of the different types of derivatives entered into by the Group.

On a notional value basis, approximately 54% of OTC interest rate contracts held as of 31 December 2019 (31 December 2018: 56%) mature within one year, 28% (31 December 2018: 28%) within one to five years and 18% (31 December 2018: 16%) after five years. Notional values of interest rate contracts cleared with a clearing house that qualify for IFRS balance sheet netting or are legally settled on a daily basis are presented under Other notional values and are categorized into maturity buckets on the basis of contractual maturities of the cleared underlying derivative contracts.

Derivatives transacted for sales and trading purposes

Most of the Group’s derivative transactions relate to sales and trading activities. Sales activities include the structuring and marketing of derivative products to customers to enable them to take, transfer, modify or reduce current or expected risks. Trading activities include market-making to directly support the facilitation and execution of client activity. Market-making involves quoting bid and offer prices to other market participants with the intention of generating revenues based on spread and volume.

Credit derivatives

UBS is an active dealer in the fixed income market, including credit default swaps (CDS) and related products, with respect to a large number of issuers’ securities. The primary objectives of these activities are ongoing hedging of trading book exposures and market-making, primarily on behalf of clients.

Market-making activity, which is undertaken within the Investment Bank, consists of buying and selling single-name CDS, index CDS, loan CDS and related referenced cash instruments to facilitate client trading activity. UBS also actively utilizes CDS to economically hedge specific counterparty credit risks in its accrual and traded loan portfolios (including off-balance sheet loan commitments) with the aim of reducing concentrations in individual names, sectors or specific portfolios.

In addition, UBS actively utilizes CDS to economically hedge specific counterparty credit risks in its OTC derivative portfolios, including financial instruments that are designated at fair value through profit or loss.

The tables below provide more information about credit protection bought and sold, including replacement and notional value information by instrument type and counterparty type. The value of protection bought and sold is not, in isolation, a measure of UBS’s credit risk. Counterparty relationships are viewed in terms of the total outstanding credit risk, which relates to other instruments in addition to CDS, and in connection with collateral arrangements in place. On a notional value basis, approximately 27% of credit protection bought and sold as of 31 December 2019 matures within one year (31 December 2018: 14%), approximately 63% within one to five years (31 December 2018: 74%) and approximately 10% after five years (31 December 2018: 12%).

Credit derivatives by type of instrument
Protection boughtProtection sold
USD billionDerivativefinancialassetsDerivativefinancialliabilitiesNotional valuesDerivativefinancialassetsDerivativefinancialliabilitiesNotional values
Single-name credit default swaps 0.3 0.7 37.5 0.8 0.7 38.6
Multi-name index-linked credit default swaps 0.1 0.8 29.3 0.5 0.1 24.9
Multi-name other credit default swaps 0.0 0.0 0.4 0.0 0.0 0.3
Total rate of return swaps 0.2 0.6 3.7 0.1 0.2 1.6
Options and warrants 0.0 0.0 3.8 0.0 0.0 0.1
Total 31 December 2019 0.7 2.1 74.6 1.3 0.9 65.4
of which: credit derivatives related to economic hedges 0.6 1.7 56.1 0.9 0.8 45.7
of which: credit derivatives related to market-making 0.1 0.4 18.6 0.5 0.1 19.7
Protection boughtProtection sold
USD billionDerivativefinancialassetsDerivativefinancialliabilitiesNotional valuesDerivativefinancialassetsDerivativefinancialliabilitiesNotional values
Single-name credit default swaps 0.6 0.6 43.3 0.5 1.0 44.9
Multi-name index-linked credit default swaps 0.3 0.3 29.1 0.3 0.2 24.4
Multi-name other credit default swaps 0.0 0.0 0.1 0.0 0.0 0.1
Total rate of return swaps 0.2 0.7 4.7 0.0 0.0 2.0
Options and warrants 0.0 0.0 4.1 0.0 0.0 0.1
Total 31 December 2018 1.1 1.6 81.3 0.8 1.2 71.4
of which: credit derivatives related to economic hedges 0.9 1.3 59.2 0.5 1.1 48.9
of which: credit derivatives related to market-making 0.2 0.4 22.1 0.3 0.2 22.6

Credit derivatives by counterparty
Protection boughtProtection sold
USD billionDerivativefinancialassetsDerivativefinancialliabilitiesNotional valuesDerivativefinancialassetsDerivativefinancialliabilitiesNotional values
Broker-dealers 0.1 0.2 10.5 0.2 0.1 9.4
Banks 0.2 0.4 23.6 0.4 0.3 21.5
Central clearing counterparties 0.1 0.9 34.7 0.7 0.2 31.6
Other 0.3 0.7 5.8 0.1 0.3 2.9
Total 31 December 2019 0.7 2.1 74.6 1.3 0.9 65.4
Protection boughtProtection sold
USD billionDerivativefinancialassetsDerivativefinancialliabilitiesNotional valuesDerivativefinancialassetsDerivativefinancialliabilitiesNotional values
Broker-dealers 0.2 0.1 13.0 0.1 0.2 11.5
Banks 0.4 0.4 29.2 0.3 0.5 25.6
Central clearing counterparties 0.2 0.4 31.9 0.4 0.3 30.8
Other 0.3 0.7 7.2 0.0 0.3 3.5
Total 31 December 2018 1.1 1.6 81.3 0.8 1.2 71.4

UBS’s CDS trades are documented using industry standard forms of documentation or equivalent terms documented in a bespoke agreement. The agreements that govern CDS generally do not contain recourse provisions that would enable UBS to recover from third parties any amounts paid out by UBS.

The types of credit events that would require UBS to perform under a CDS contract are subject to agreement between the parties at the time of the transaction. However, nearly all transactions are traded with reference to credit events that are applicable under certain market conventions based on the type of reference entity to which the transaction relates. Applicable credit events according to market conventions include bankruptcy, failure to pay, restructuring, obligation acceleration and repudiation / moratorium.

Contingent collateral features of derivative liabilities

Certain derivative instruments contain contingent collateral or termination features triggered upon a downgrade of the published credit ratings of the Group in the normal course of business. Based on UBS’s credit ratings as of 31 December 2019, USD 0.0 billion, USD 0.3 billion and USD 0.8 billion would have been required for contractual obligations related to OTC derivatives in the event of a one-notch, two-notch and three-notch reduction in long-term credit ratings, respectively. In evaluating UBS’s liquidity requirements, UBS considers additional collateral or termination payments that would be required in the event of a reduction in UBS’s long-term credit ratings, and a corresponding reduction in UBS’s short-term ratings.

UBS AG  
Derivative [Line Items]  
Disclosure Of Derivative Financial Instruments Explanatory

Note 11 Derivative instruments

Derivatives: overview

A derivative is a financial instrument for which the value is derived from one or more variables (underlyings). Underlyings may be indices, foreign currency exchange or interest rates, or the value of shares, commodities, bonds or other financial instruments. A derivative commonly requires little or no initial net investment by either counterparty to the trade.

The majority of derivative contracts are negotiated with respect to notional amounts, tenor, price and settlement mechanisms, as is customary with other financial instruments.

Over-the-counter (OTC) derivative contracts are usually traded under a standardized International Swaps and Derivatives Association (ISDA) master agreement between UBS AG and its counterparties. Terms are negotiated directly with counterparties and the contracts have industry standard settlement mechanisms prescribed by ISDA. Beginning in 2016, regulators in various jurisdictions began a phased introduction of rules requiring the payment and collection of initial and variation margin on certain OTC derivative contracts, which may have a bearing on their price and other relevant terms. Under the final rules of the Basel Committee on Banking Supervision (BCBS) and the Board of the International Organization of Securities Commissions (IOSCO) promulgated in July 2019, the final phase-in of margin requirements for non-centrally cleared derivatives will be completed on 1 September 2021.

The industry continues to promote the use of central counterparties (CCPs) to clear OTC trades. The trend toward CCP clearing and settlement will generally facilitate the reduction of systemic credit exposures.

Other derivative contracts are standardized in terms of their amounts and settlement dates, and are bought and sold on regulated exchanges. These are commonly referred to as exchange-traded derivatives (ETD) contracts. Exchanges offer the benefits of pricing transparency, standardized daily settlement of changes in value and consequently reduced credit risk.

For presentation purposes, UBS AG’s derivative contracts are subject to IFRS netting provisions. Derivative instruments are measured at fair value and generally classified on the balance sheet as Derivative financial instruments within Assets when having positive replacement values and Derivative financial instruments within Liabilities when having negative replacement values. However, ETD that are economically settled on a daily basis and OTC derivatives that are either legally settled or in substance net settled on a daily basis are classified as Cash collateral receivables on derivative instruments or Cash collateral payables on derivative instruments. Changes in the replacement values of derivatives are recorded in Other net income from financial instruments measured at fair value through profit or loss, except for interest on derivatives designated as hedging instruments in effective hedge accounting relationships and forward points on certain short- and long-duration foreign exchange contracts, which are recorded in Net interest income.

Refer to Note 1a items 3j and 3k for more information

Refer to Note 25 for more information about derivative financial assets and liabilities after consideration of netting potential allowed under enforceable netting arrangements

UBS AG uses various derivative instruments for both trading and hedging purposes. Derivative product types as well as valuation principles and techniques applied by UBS AG are described in Note 24. Positive replacement values represent the estimated amount UBS AG would receive if the derivative contract were sold on the balance sheet date. Negative replacement values indicate the estimated amount UBS AG would pay to transfer its obligations in respect of the underlying contract were it required or entitled to do so on the balance sheet date.

Derivatives embedded in other financial instruments are not included in the “Derivative instruments” table within this Note. Bifurcated embedded derivatives are presented on the same balance sheet line as the host contract. In cases where UBS AG applies the fair value option to hybrid instruments, bifurcation of an embedded derivative component is not required and as such this component is also not included in the “Derivative instruments” table.

Refer to Notes 19 and 24 for more information

Risks of derivative instruments

Derivative instruments are transacted in many trading portfolios, which generally include several types of instruments, not just derivatives. The market risk of derivatives is predominantly managed and controlled as an integral part of the market risk of these portfolios. UBS AG’s approach to market risk is described in the audited portions of “Market risk” in the “Risk management and control” section of this report.

Derivative instruments are also transacted with many different counterparties, most of whom are also counterparties for other types of business. The credit risk of derivatives is managed and controlled in the context of UBS AG’s overall credit exposure to its counterparties. UBS AG’s approach to credit risk is described in the audited portions of “Credit risk” in the “Risk management and control” section of this report. It should be noted that, although the derivative financial assets shown on the balance sheet can be an important component of UBS AG’s credit exposure, the positive replacement values related to a respective counterparty are rarely an adequate reflection of UBS AG’s credit exposure in its derivatives business with that counterparty. This is generally the case because, on the one hand, replacement values can increase over time (potential future exposure), while on the other hand, exposure may be mitigated by entering into master netting agreements and bilateral collateral arrangements. Both the exposure measures used internally by UBS AG to control credit risk and the capital requirements imposed by regulators reflect these additional factors.

Refer to Note 25 for more information about derivative financial assets and liabilities after consideration of netting potential allowed under enforceable netting arrangements

Derivative instruments¹,²

31.12.1931.12.18
USD billionDerivativefinancialassetsNotional valuesrelated to derivativefinancial assets3DerivativefinancialliabilitiesNotional valuesrelated to derivativefinancial liabilities3Other notional values3,4DerivativefinancialassetsNotional valuesrelated to derivativefinancial assets3DerivativefinancialliabilitiesNotional valuesrelated to derivativefinancial liabilities3Other notional values3,4
Interest rate contracts
Over-the-counter (OTC) contracts
Forward contracts 0.0 2.8 0.3 5.1 3,136.8 0.0 1.4 0.1 3.1 2,873.9
Swaps 34.3 454.7 26.2 402.9 8,086.0 29.5 459.8 23.5 441.8 7,189.1
Options 8.1 464.8 10.0 486.1 7.6 562.2 9.0 550.0
Exchange-traded contracts
Futures 546.9 516.1
Options 0.0 84.4 0.0 66.6 229.5 0.0 27.7 0.0 26.3 199.7
Agency transactions5 0.1 0.1 0.0 0.1
Total 42.6 1,006.6 36.6 960.7 11,999.2 37.1 1,051.1 32.7 1,021.3 10,778.8
Credit derivative contracts
Over-the-counter (OTC) contracts
Credit default swaps 1.7 65.0 2.2 66.0 1.7 68.8 2.1 73.2
Total return swaps 0.3 2.0 0.8 3.3 0.2 3.0 0.6 3.7
Options and warrants 0.0 3.3 0.0 0.6 0.0 2.7 0.0 1.4
Total 2.0 70.2 3.0 69.9 1.9 74.5 2.7 78.3
Foreign exchange contracts
Over-the-counter (OTC) contracts
Forward contracts 22.4 935.5 23.4 966.6 20.3 708.8 20.9 731.2
Interest and currency swaps 22.8 1,573.2 23.8 1,418.5 24.8 1,299.7 24.6 1,203.5
Options 7.3 660.9 6.8 604.9 8.3 613.8 7.8 577.4
Exchange-traded contracts
Futures 1.2 0.4
Options 0.0 4.0 0.0 3.8 0.0 3.6 0.0 5.3
Agency transactions5 0.0 0.0 0.0 0.1
Total 52.5 3,173.6 54.0 2,993.8 1.2 53.5 2,625.8 53.4 2,517.3 0.4
Equity / index contracts
Over-the-counter (OTC) contracts
Forward contracts 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Swaps 4.0 81.3 5.5 96.3 4.7 78.5 5.6 86.3
Options 5.0 88.6 6.8 144.1 5.5 97.6 7.2 139.6
Exchange-traded contracts
Futures 84.9 71.7
Options 7.2 250.4 7.8 294.1 37.2 10.1 232.8 9.0 262.8 34.1
Agency transactions5 6.6 5.4 11.2 13.3
Total 22.8 420.3 25.5 534.5 122.1 31.4 408.9 35.0 488.8 105.9
Derivative instruments (continued)1,2
31.12.1931.12.18
USD billionDerivativefinancialassetsNotional valuesrelated to derivativefinancial assets3DerivativefinancialliabilitiesNotional valuesrelated to derivativefinancial liabilities3Other notional values3,4DerivativefinancialassetsNotional valuesrelated to derivativefinancial assets3DerivativefinancialliabilitiesNotional valuesrelated to derivativefinancial liabilities3Other notional values3,4
Commodity contracts
Over-the-counter (OTC) contracts
Forward contracts 0.1 4.2 0.2 5.7 0.1 3.2 0.1 3.4
Swaps 0.4 13.8 0.6 15.1 0.7 15.2 0.4 9.9
Options 1.0 27.4 0.4 23.6 0.4 18.6 0.3 16.1
Exchange-traded contracts
Futures 12.0 8.5
Forward contracts 0.0 5.9 0.0 4.9 0.0 6.6 0.0 5.4
Options 0.1 4.8 0.1 10.7 0.6 0.1 2.9 0.0 3.7 0.1
Agency transactions5 0.3 0.5 0.4 0.7
Total 1.8 56.1 1.7 60.0 12.6 1.8 46.4 1.5 38.5 8.6
Unsettled purchases of non-derivative financial instruments6 0.1 16.6 0.1 6.9 0.2 17.0 0.1 6.0
Unsettled sales of non-derivative financial instruments6 0.1 15.4 0.1 9.7 0.4 15.1 0.2 13.2
Total derivative instruments, based on IFRS netting7 121.8 4,758.9 120.9 4,635.4 12,135.1 126.2 4,238.7 125.7 4,163.4 10,893.6
1 Derivative financial liabilities as of 31 December 2019 include USD 17 million related to derivative loan commitments (31 December 2018: USD 17 million). No notional amounts related to these commitments are included in this table, but they are disclosed in Note 34 under Loan commitments. 2 Includes certain forward starting repurchase and reverse repurchase agreements that are classified as measured at fair value through profit or loss and are recognized within derivative instruments. The fair value of these derivative instruments was not material as of 31 December 2019 or 31 December 2018. No notional amounts related to these instruments are included in this table, but they are disclosed in Note 34 under Forward starting transactions. 3 In cases where derivative financial instruments are presented on a net basis on the balance sheet, the respective notional values of the netted derivative financial instruments are still presented on a gross basis. 4 Other notional values relate to derivatives that are cleared through either a central counterparty or an exchange. The fair value of these derivatives is presented on the balance sheet net of the corresponding cash margin under Cash collateral receivables on derivative instruments and Cash collateral payables on derivative instruments and was not material for all periods presented. 5 Notional values of exchange-traded agency transactions and OTC-cleared transactions entered into on behalf of clients are not disclosed as they have a significantly different risk profile. 6 Changes in the fair value of purchased and sold non-derivative financial instruments between trade date and settlement date are recognized as derivative financial instruments. 7 Financial assets and liabilities are presented net on the balance sheet if UBS AG has the unconditional and legally enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of the entity and all of the counterparties, and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously. Refer to Note 25 for more information on netting arrangements.

The notional amount of a derivative is generally the quantity of the underlying instrument on which the derivative contract is based and is the reference against which changes in the value of the derivative are measured. Notional values in themselves are generally not a direct indication of the values that are exchanged between parties, and are therefore not a direct measure of risk or financial exposure but are viewed as an indication of the scale of the different types of derivatives entered into by UBS AG.

On a notional value basis, approximately 54% of OTC interest rate contracts held as of 31 December 2019 (31 December 2018: 56%) mature within one year, 28% (31 December 2018: 28%) within one to five years and 18% (31 December 2018: 16%) after five years. Notional values of interest rate contracts cleared with a clearing house that qualify for IFRS balance sheet netting or are legally settled on a daily basis are presented under Other notional values and are categorized into maturity buckets on the basis of contractual maturities of the cleared underlying derivative contracts.

Derivatives transacted for sales and trading purposes

Most of UBS AG’s derivative transactions relate to sales and trading activities. Sales activities include the structuring and marketing of derivative products to customers to enable them to take, transfer, modify or reduce current or expected risks. Trading activities include market-making to directly support the facilitation and execution of client activity. Market-making involves quoting bid and offer prices to other market participants with the intention of generating revenues based on spread and volume.

Credit derivatives

UBS AG is an active dealer in the fixed income market, including credit default swaps (CDS) and related products, with respect to a large number of issuers’ securities. The primary objectives of these activities are ongoing hedging of trading book exposures and market-making, primarily on behalf of clients.

Market-making activity, which is undertaken within the Investment Bank, consists of buying and selling single-name CDS, index CDS, loan CDS and related referenced cash instruments to facilitate client trading activity. UBS AG also actively utilizes CDS to economically hedge specific counterparty credit risks in its accrual and traded loan portfolios (including off-balance sheet loan commitments) with the aim of reducing concentrations in individual names, sectors or specific portfolios.

In addition, UBS AG actively utilizes CDS to economically hedge specific counterparty credit risks in its OTC derivative portfolios, including financial instruments that are designated at fair value through profit or loss.

The tables below provide more information about credit protection bought and sold, including replacement and notional value information by instrument type and counterparty type. The value of protection bought and sold is not, in isolation, a measure of UBS AG’s credit risk. Counterparty relationships are viewed in terms of the total outstanding credit risk, which relates to other instruments in addition to CDS, and in connection with collateral arrangements in place. On a notional value basis, approximately 27% of credit protection bought and sold as of 31 December 2019 matures within one year (31 December 2018: 14%), approximately 63% within one to five years (31 December 2018: 74%) and approximately 10% after five years (31 December 2018: 12%).

Credit derivatives by type of instrument
Protection boughtProtection sold
USD billionDerivativefinancialassetsDerivativefinancialliabilitiesNotional valuesDerivativefinancialassetsDerivativefinancialliabilitiesNotional values
Single-name credit default swaps 0.3 0.7 37.5 0.8 0.7 38.6
Multi-name index-linked credit default swaps 0.1 0.8 29.3 0.5 0.1 24.9
Multi-name other credit default swaps 0.0 0.0 0.4 0.0 0.0 0.3
Total rate of return swaps 0.2 0.6 3.7 0.1 0.2 1.6
Options and warrants 0.0 0.0 3.8 0.0 0.0 0.1
Total 31 December 2019 0.7 2.1 74.6 1.3 0.9 65.4
of which: credit derivatives related to economic hedges 0.6 1.7 56.1 0.9 0.8 45.7
of which: credit derivatives related to market-making 0.1 0.4 18.6 0.5 0.1 19.7
Protection boughtProtection sold
USD billionDerivativefinancialassetsDerivativefinancialliabilitiesNotional valuesDerivativefinancialassetsDerivativefinancialliabilitiesNotional values
Single-name credit default swaps 0.6 0.6 43.3 0.5 1.0 44.9
Multi-name index-linked credit default swaps 0.3 0.3 29.1 0.3 0.2 24.4
Multi-name other credit default swaps 0.0 0.0 0.1 0.0 0.0 0.1
Total rate of return swaps 0.2 0.7 4.7 0.0 0.0 2.0
Options and warrants 0.0 0.0 4.1 0.0 0.0 0.1
Total 31 December 2018 1.1 1.6 81.3 0.8 1.2 71.4
of which: credit derivatives related to economic hedges 0.9 1.3 59.2 0.5 1.1 48.9
of which: credit derivatives related to market-making 0.2 0.4 22.1 0.3 0.2 22.6

Credit derivatives by counterparty
Protection boughtProtection sold
USD billionDerivativefinancialassetsDerivativefinancialliabilitiesNotional valuesDerivativefinancialassetsDerivativefinancialliabilitiesNotional values
Broker-dealers 0.1 0.2 10.5 0.2 0.1 9.4
Banks 0.2 0.4 23.6 0.4 0.3 21.5
Central clearing counterparties 0.1 0.9 34.7 0.7 0.2 31.6
Other 0.3 0.7 5.8 0.1 0.3 2.9
Total 31 December 2019 0.7 2.1 74.6 1.3 0.9 65.4
Protection boughtProtection sold
USD billionDerivativefinancialassetsDerivativefinancialliabilitiesNotional valuesDerivativefinancialassetsDerivativefinancialliabilitiesNotional values
Broker-dealers 0.2 0.1 13.0 0.1 0.2 11.5
Banks 0.4 0.4 29.2 0.3 0.5 25.6
Central clearing counterparties 0.2 0.4 31.9 0.4 0.3 30.8
Other 0.3 0.7 7.2 0.0 0.3 3.5
Total 31 December 2018 1.1 1.6 81.3 0.8 1.2 71.4

UBS AG’s CDS trades are documented using industry standard forms of documentation or equivalent terms documented in a bespoke agreement. The agreements that govern CDS generally do not contain recourse provisions that would enable UBS AG to recover from third parties any amounts paid out by UBS AG.

The types of credit events that would require UBS AG to perform under a CDS contract are subject to agreement between the parties at the time of the transaction. However, nearly all transactions are traded with reference to credit events that are applicable under certain market conventions based on the type of reference entity to which the transaction relates. Applicable credit events according to market conventions include bankruptcy, failure to pay, restructuring, obligation acceleration and repudiation / moratorium.

Contingent collateral features of derivative liabilities

Certain derivative instruments contain contingent collateral or termination features triggered upon a downgrade of the published credit ratings of UBS AG in the normal course of business. Based on UBS AG’s credit ratings as of 31 December 2019, USD 0.0 billion, USD 0.3 billion and USD 0.8 billion would have been required for contractual obligations related to OTC derivatives in the event of a one-notch, two-notch and three-notch reduction in long-term credit ratings, respectively. In evaluating UBS AG’s liquidity requirements, UBS AG considers additional collateral or termination payments that would be required in the event of a reduction in UBS AG’s long-term credit ratings, and a corresponding reduction in UBS AG’s short-term ratings.